Mallika Pradhan MD

Recommended Articles

• What Is a Barrel Chest?

  Barrel Chest A barrel chest refers to an individual's chest that appears to be always partially inflated. It looks as if they are taking a deep breath with their rib cage broadened. An individual with a barrel chest may find it hard to breathe.A barrel chest may develop due to osteoarthritis or...

• What Is Bronchitis?

  Bronchitis is inflammation of the cells lining your bronchial airways. Bronchitis affects males more than the females. Bronchitis can be due to an infection (viral or bacterial in origin), inhalation of smoke, dust or any other irritating substance....

• 47-year-old with Cystic Fibrosis Refuses to Let It Stop Her

  Sue Britton, a 47-year-old woman has cystic fibrosis. In her 20s, she became tired of being known and labeled as the ‘sick girl’, so she left her home to embark on a 7-month journey around the world. The fact that she had cystic fibrosis and needed medication on a daily basis did not stop her....

• Boomer Esiason’s Son Still Coaching Despite Cystic Fibrosis

  Despite the challenges that someone with cystic fibrosis faces, it’s still possible for them to live a full, happy life. Gunnar Esiason is a perfect example of this.Gunnar is the son of Boomer Esiason, famed former NFL quarterback. Gunnar’s story was famously profiled in Sports Illustrated in...

• Stem Cell Therapy Can Reduce Inflammation in Cystic Fibrosis

  Cystic fibrosis can cause numerous lung infections that will lead to lung damage and a weaker respiratory system. Scientists have therefore taken to researching different rehabilitation methods on repairing lung damage. There have been a number of recent breakthroughs in lung rehabilitation, but one...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...